1. ORCHID PHARMA
stock logo

100% Buy

ORCHID PHARMA Share Price

ORCHPHARMA

₹1,064.80-₹6.40 (-0.6%) Past YearLast updated on 19 Apr, 2024 | 03:44 PM IST
₹1,038.55₹1,076.20
L
Show Current Price
H
  • News

  • Company overview

  • Fundamentals

  • Events

  • More

Company overview

About

arrow

Market cap

Market Cap Switch₹5,433 Cr

Open

₹1,060.00

Close

₹1,071.20

Circuit range

₹1,285.40 - ₹857.00

Day range

₹1,038.55 - ₹1,076.20

Year range

₹372.65 - ₹1,359.95

Volume

50,053

Avg. traded

₹1,064.11

Revenue (12m)

₹812 Cr

ORCHID PHARMAOrchid Pharma Limited is an India-based pharmaceutical company. The Company is engaged in the manufacturing of integrated active pharmaceutical ingredients (API). It operates through the pharmaceutical segment. It has a multi-therapeutic presence across segments like anti-infectives, anti-inflammatory, central nervous system (CNS), cardiovascular segment (CVS), nutraceuticals and other oral and sterile products. Its pharmaceutical solutions include active pharmaceutical ingredients (APIs) and finished dosage forms. It offers APIs, including Cephalosporins-Orals, Cephalosporins-Injectables, Veterinary Products and Non-Antibodies. Its formulations include Cefixime Capsules, Acarbose Tablets, Acarbose Tablets, Clozapime Tablets, Clopidogrel Tablets, Desloratadine Tablets and Cefoperazone and Sulbactam for Injection, among others. Its subsidiaries include Orchid Europe Limited, Orchid Pharmaceuticals Inc., Bexel Pharmaceuticals Inc., and Diakron Pharmaceuticals, Inc., among others.

Read more

ORCHID PHARMA Key indicators

arrow

52 week high

₹1,359.95

52 week low

₹372.65

P/E ratio

37.59

P/B ratio

4.75

ROE

7.84%

ROCE

8.77%

Dividend yield

--

Debt/Equity ratio

0.45

EPS

13.54

Learn more

Investment checklist: (2/6)

arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Analyst ratings:

Buy

arrow

Buy

100%

Hold

0%

Sell

0%

This analysis is based on the reviews of 1 experts in the last 7 days

Fundamentals

Financial ratios

arrow
  • Profitability

  • Operational

  • Valuation

Operating profit margin

15.58%

Net profit margin

8.3%

ROE

7.84%

ROA

4.77%

ROCE

8.77%

Learn more

ORCHID PHARMA Shareholder returns

arrow

1 day

-2.65%

1 week

-9.30%

1 month

+3.38%

3 months

+46.79%

1 year

+175.98%

3 years

-32.77%

5 years

+5851.11%

Revenue statement

All values are in ₹ Crores (Cr)
arrow
Empty state

No data available at the moment

Cash flow

All values are in ₹ Crores (Cr)
arrow
Empty state

No data available at the moment

Balance sheet

All values are in ₹ Crores (Cr)
arrow
Empty state

No data available at the moment

ORCHID PHARMA Share Price history

arrow
DayOpenCloseDay’s change
Fri, Apr 19 2024
₹1,060.00
₹1,064.80
+0.45%
Thu, Apr 18 2024
₹1,119.00
₹1,071.20
-4.46%
Tue, Apr 16 2024
₹1,037.10
₹1,100.40
+5.75%
Mon, Apr 15 2024
₹1,069.95
₹1,098.95
+2.64%
Fri, Apr 12 2024
₹1,140.00
₹1,088.90
-4.69%
Wed, Apr 10 2024
₹1,206.95
₹1,160.00
-4.05%
Tue, Apr 9 2024
₹1,150.00
₹1,181.05
+2.63%
Mon, Apr 8 2024
₹1,105.00
₹1,131.00
+2.30%

Shareholding info

arrow

Promoters (69.84%)

Mutual Funds (10.4%)

Retail and other (11.53%)

Foreign institutions-FII (4.14%)

Other domestic institutions (4.1%)

Promoters

Learn more

Events

Empty state

No data available at the moment

Frequently asked questions